Lupocet Trio 1000 mg/200 mg/12,2 mg prašak za oralnu otopinu u vrećici
| Name | Lupocet Trio 1000 mg/200 mg/12,2 mg prašak za oralnu otopinu u vrećici |
|---|---|
| Marketing Authorisation Number | HR-H-337689910 |
| Active Substance | paracetamol gvaifenezin fenilefrinklorid |
| Composition | svaka vrećica sadrži 1000 mg paracetamola, 200 mg gvaifenezina i 12,2 mg fenilefrinklorida (što odgovara 10 mg fenilefrin baze) |
| Pharmaceutical Form | Prašak za oralnu otopinu u vrećici |
| Manufacturer | Belupo lijekovi i kozmetika d.d., Koprivnica, Hrvatska |
| Marketing Authorisation Holder | Belupo lijekovi i kozmetika d.d., Ulica Danica 5, Koprivnica, Hrvatska |
| Marketing Authorisation Date | 18.07.2022 |
| MA Period of Validity | 18.07.2027 |
| Classification Number | UP/I-530-09/21-01/145 |
| Registration Number | 381-12-01/38-22-07 |
| Prescription | Medicinal product not subject to medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | allowed |
| ATC Code | N02BE51 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
